Dr Martens PLC (DOCS.L) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · United Kingdom · ISIN GB00BL6NGV24
Price
0.66 GBP
Market cap
643.60 m GBP
P/E (2026)
27.37
P/S (2026)
0.84
Dividend yield
3.88 %
Net margin
3.11 %
Return on equity (ROE)
6.58 %
Return on assets (ROA)
2.71 %
Dr Martens PLC financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 787.00 m GBP | 764.90 m GBP |
| Gross profit | 511.00 m GBP | 506.00 m GBP |
| Operating income | 60.70 m GBP | 73.40 m GBP |
| EBIT | 69.00 m GBP | – |
| Net income | 4.50 m GBP | 23.80 m GBP |
| Diluted EPS – continuing operations | 0.00 GBP | 0.02 GBP |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Dr Martens PLC
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
More stocks
- Trican Well Service Ltd. (TCW.TO)
- Power HF Co Ltd (605100.SS)
- Dynamic Holding Co. Ltd. (3715.TW)
- PharmaResources (Shanghai) Co. Ltd. A (301230.SZ)
- D-MARKET Electronic Services & Trading ADR (HEPS)
- Shenzhen JingQuanHua Electronics Co Ltd (002885.SZ)
- Beijing Watertek Information Technology Co Ltd (300324.SZ)
- ALERUS FINANCIAL CORP (ALRS)
- RoboSense Technology Co Ltd (2498.HK)
- Beta Bionics, Inc. (BBNX)
- MARCUS CORP (MCS)
- Kayne Anderson BDC, Inc. (KBDC)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.